Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,688 | -51,610 | -24,886 | -75,305 | -51,392 |
| Depreciation Amortization | 2,207 | 1,286 | 538 | 350 | 132 |
| Accounts payable and accrued liabilities | -1,693 | -4,045 | -2,338 | N/A | 653 |
| Other Working Capital | 848 | 1,659 | 559 | 4,310 | 4,682 |
| Other Operating Activity | 19,109 | 9,532 | 3,793 | 4,512 | 2,553 |
| Operating Cash Flow | $-67,217 | $-43,178 | $-22,334 | $-66,133 | $-43,372 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 300,056 | 210,556 | 107,000 | N/A | 117,000 |
| PPE Investments | -1,867 | -1,434 | -1,020 | -7,982 | -7,384 |
| Purchase Of Investment | -140,097 | -71,103 | -55,609 | N/A | -464,537 |
| Other Investing Activity | 0 | 0 | 0 | -311,042 | 0 |
| Investing Cash Flow | $158,092 | $138,019 | $50,371 | $-319,024 | $-354,921 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 428,960 | 718 | 351 | N/A | 172 |
| Other Financing Activity | -2,507 | -460 | 0 | 5,606 | 5,661 |
| Financing Cash Flow | $426,453 | $258 | $351 | $5,606 | $5,833 |
| Beginning Cash Position | 42,832 | 42,832 | 42,832 | 422,383 | 422,383 |
| End Cash Position | 560,160 | 137,931 | 71,220 | 42,832 | 29,923 |
| Net Cash Flow | $517,328 | $95,099 | $28,388 | $-379,551 | $-392,460 |
| Free Cash Flow | |||||
| Operating Cash Flow | -67,217 | -43,178 | -22,334 | -66,133 | -43,372 |
| Capital Expenditure | -1,867 | -1,434 | -1,020 | N/A | -7,404 |
| Free Cash Flow | -69,084 | -44,612 | -23,354 | -66,133 | -50,776 |